INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, published by BMJ PUBLISHING GROUP, is a leading interdisciplinary journal focused on advancing research and clinical practice in the field of gynecological oncology. With an ISSN of 1048-891X and an E-ISSN of 1525-1438, the journal has established itself as a vital resource since its inception in 1991, covering cutting-edge advancements through 2024 and beyond. The journal holds esteemed rankings, including Q1 in Obstetrics and Gynecology and Q2 in Oncology, highlighting its influence and high citation impact within the medical community. Its Scopus rankings underscore its prominence, placing it among the top 13% of journals in Obstetrics and Gynecology and the top 27% in Oncology. Although it does not currently offer Open Access options, the journal provides a platform for researchers, clinicians, and students to share significant findings and developments that shape the future of gynecological cancer research and treatment. The INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER stands as a significant pillar in the ongoing effort to improve patient outcomes and foster innovation in this critical area of healthcare.

ORAL DISEASES, published by Wiley, stands out as a leading journal in the fields of Dentistry and Otorhinolaryngology, with its Q1 ranking reflecting its high impact and esteemed contribution to the scientific community. Since its inception in 1995, this journal has consistently provided a platform for the latest research and clinical developments pertaining to oral health and diseases, promoting an interdisciplinary approach that bridges dentistry and ENT practices. With a strong emphasis on innovation and evidence-based findings, ORAL DISEASES is essential for researchers, practitioners, and students keen on advancing their knowledge of oral and related systemic health issues. Accessibility may vary, and while it is not an Open Access journal, its substantial readership underscores its critical role in shaping contemporary oral health discourse. For those passionate about making significant contributions to the field, engaging with the groundbreaking research published in this journal is an invaluable opportunity.

The Journal of Head & Neck Physicians and Surgeons, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of oncology, oral surgery, otorhinolaryngology, and surgery. Since its transition to Open Access in 2016, the journal has endeavored to disseminate high-quality research and advancements within these specialized areas, fostering collaboration and knowledge sharing among professionals, researchers, and students. With an ISSN of 2347-8128, this journal has established its presence from India and operates with a commitment to rigorous peer review and academic integrity. Despite its relatively recent standing reflected in a Q4 category across several disciplines as well as modest Scopus rankings, the journal's focus on niche scientific studies provides a platform for impactful research to reach practitioners and scholars globally. Continuously adapting to the evolving landscape of medical science, the Journal of Head & Neck Physicians and Surgeons aims to be an essential publication for those aiming to enhance their understanding and clinical practices related to head and neck conditions.

JCO Precision Oncology, published by Lippincott Williams & Wilkins, is a leading journal in the field of cancer research and oncology, recognized for its high-impact contributions and innovative approaches to precision medicine. Since its inception in 2017, this journal has consistently ranked in the Q1 category in both Cancer Research and Oncology for 2023, reflecting its esteemed position within the academic community. With a rigorous peer-review process and a focus on disseminating cutting-edge research, JCO Precision Oncology serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to enhance the understanding and treatment of cancer through individualized therapies. The journal's comprehensive scope includes studies on genetic profiling, biomarker research, and novel therapeutic strategies, making it an essential resource for anyone involved in cancer care and research. Explore further and join a community committed to advancing precision oncology and improving patient outcomes.

CLINICAL OTOLARYNGOLOGY is a prestigious peer-reviewed journal published by Wiley that focuses on advancing research in the field of otorhinolaryngology, including topics such as laryngeal surgery, sinus diseases, and head and neck oncology. With an ISSN of 1749-4478 and an E-ISSN of 1749-4486, this journal has established itself as a vital resource for healthcare professionals, researchers, and students interested in ear, nose, and throat (ENT) medicine. The journal is recognized for its rigorous standards, exemplified by its Q2 ranking in both the Medicine (Miscellaneous) and Otorhinolaryngology categories, as per the 2023 Scopus ranking, placing it within the 71st percentile among global journals in its field. Operating from its UK base in Hoboken, NJ, CLINICAL OTOLARYNGOLOGY also contributes to the scientific community's understanding of this specialized area of medicine, with a publication timeline spanning from 2005 to 2024. While it does not offer an open-access model, the journal's quality and impact make it a crucial platform for disseminating high-caliber research that informs clinical practices and fosters innovation in otolaryngology.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, is a premier journal dedicated to advancing the fields of hematology and oncology. With its ISSN 0889-8588 and E-ISSN 1558-1977, this esteemed publication has been a cornerstone of clinical scholarship since its inception in 1987, providing comprehensive annual updates that bridge the gap between research and clinical practice. Known for its rigorous editorial standards and impactful contributions, the journal holds a respectable Q2 quartile classification in both hematology and oncology as of 2023, ranking it in the 50th percentile among its peers. Although it is not an open-access journal, the content is accessible to institutions and professionals worldwide. As the scope of the journal expands through 2024, it continues to attract an audience of researchers, healthcare professionals, and students who seek to stay informed on the latest advancements, treatment modalities, and groundbreaking studies in the fields of hematology and oncology.

Translational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.

Oral Science International is a distinguished academic journal published by WILEY, focusing on the multidisciplinary field of otorhinolaryngology. With an ISSN of 1348-8643 and an E-ISSN of 1881-4204, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and innovations in oral and maxillofacial sciences. Established over two decades ago, it has steadily built a solid reputation within the scientific community, currently holding a Q3 ranking in the 2023 Otorhinolaryngology category and ranking #77 out of 123 on the Scopus scale, placing it in the 37th percentile. Although it is not an Open Access journal, Oral Science International continues to provide pivotal insights that drive research and professional practice forward. Located in Japan, this journal emphasizes the importance of global collaboration and knowledge sharing in advancing oral health care and associated disciplines.

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY is a premier peer-reviewed journal published by Churchill Livingstone, dedicated to advancing the field of oral and maxillofacial surgery. With an impressive Q1 ranking in the categories of Oral Surgery, Otorhinolaryngology, and Surgery as of 2023, this journal serves as a vital resource for researchers, clinicians, and students alike, offering cutting-edge research findings, clinical studies, and innovative surgical techniques. The journal covers a wide range of topics within its scope, ensuring that it remains at the forefront of advancements in surgical practice and patient care. Though it operates under a traditional access model, its Impact Factor reflects its significance in the field and its role in disseminating critical knowledge. Established in 1986, the INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY continues to be an essential tool for those dedicated to enhancing therapeutic outcomes and surgical methodologies, solidifying its position as a trusted resource in the ongoing evolution of maxillofacial sciences.

World Journal of Clinical Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a vital resource in the realm of oncology, providing a dedicated platform for the dissemination of cutting-edge research and clinical advancements. With an ISSN of 2218-4333, this journal facilitates a comprehensive exploration of modern oncology challenges and breakthroughs, targeting researchers, healthcare professionals, and students alike. Although it operates under the traditional subscription model, the impactful nature of its content is reflected in its notable ranking of 60 out of 334 in the category of Medicine _ Oncology, placing it in the 82nd percentile among peer publications. Covering significant topics in clinical oncology from 2014 to 2018, the journal has been instrumental in addressing evolving oncology practices and patient care innovations. By publishing high-quality studies, it remains an essential tool for advancing knowledge and fostering collaboration within the global oncology community.